251 related articles for article (PubMed ID: 16267130)
21. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
Ai D; Fu Y; Guo D; Tanaka H; Wang N; Tang C; Hammock BD; Shyy JY; Zhu Y
Proc Natl Acad Sci U S A; 2007 May; 104(21):9018-23. PubMed ID: 17495027
[TBL] [Abstract][Full Text] [Related]
23. A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow in the rat.
Iliff JJ; Close LN; Selden NR; Alkayed NJ
Exp Physiol; 2007 Jul; 92(4):653-8. PubMed ID: 17639071
[TBL] [Abstract][Full Text] [Related]
24. CYP2J2
Tao P; Jiang Y; Wang H; Gao G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):932-941. PubMed ID: 34707002
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
[TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice.
Hoopes SL; Gruzdev A; Edin ML; Graves JP; Bradbury JA; Flake GP; Lih FB; DeGraff LM; Zeldin DC
PLoS One; 2017; 12(4):e0175348. PubMed ID: 28384353
[TBL] [Abstract][Full Text] [Related]
27. sEH promotes macrophage phagocytosis and lung clearance of Streptococcus pneumoniae.
Li H; Bradbury JA; Edin ML; Graves JP; Gruzdev A; Cheng J; Hoopes SL; DeGraff LM; Fessler MB; Garantziotis S; Schurman SH; Zeldin DC
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34591792
[TBL] [Abstract][Full Text] [Related]
28. Eicosapentaenoic acid increases cytochrome P-450 2J2 gene expression and epoxyeicosatrienoic acid production via peroxisome proliferator-activated receptor γ in endothelial cells.
Wang D; Hirase T; Nitto T; Soma M; Node K
J Cardiol; 2009 Dec; 54(3):368-74. PubMed ID: 19944311
[TBL] [Abstract][Full Text] [Related]
29. Epoxyeicosatrienoic acid pathway in human health and diseases.
Bellien J; Joannides R
J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.
Vriens J; Owsianik G; Fisslthaler B; Suzuki M; Janssens A; Voets T; Morisseau C; Hammock BD; Fleming I; Busse R; Nilius B
Circ Res; 2005 Oct; 97(9):908-15. PubMed ID: 16179585
[TBL] [Abstract][Full Text] [Related]
31. Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner.
Cizkova K
Toxicol Appl Pharmacol; 2018 Sep; 355():156-163. PubMed ID: 29960002
[TBL] [Abstract][Full Text] [Related]
32. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
Fleming I
Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
[TBL] [Abstract][Full Text] [Related]
33. Astaxanthin functions differently as a selective peroxisome proliferator-activated receptor γ modulator in adipocytes and macrophages.
Inoue M; Tanabe H; Matsumoto A; Takagi M; Umegaki K; Amagaya S; Takahashi J
Biochem Pharmacol; 2012 Sep; 84(5):692-700. PubMed ID: 22732454
[TBL] [Abstract][Full Text] [Related]
34. Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.
Merabet N; Bellien J; Glevarec E; Nicol L; Lucas D; Remy-Jouet I; Bounoure F; Dreano Y; Wecker D; Thuillez C; Mulder P
J Mol Cell Cardiol; 2012 Mar; 52(3):660-6. PubMed ID: 22155238
[TBL] [Abstract][Full Text] [Related]
35. Artepillin C, as a PPARγ ligand, enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
Choi SS; Cha BY; Iida K; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
Biochem Pharmacol; 2011 Apr; 81(7):925-33. PubMed ID: 21219874
[TBL] [Abstract][Full Text] [Related]
36. Mode of peroxisome proliferator-activated receptor γ activation by luteolin.
Puhl AC; Bernardes A; Silveira RL; Yuan J; Campos JL; Saidemberg DM; Palma MS; Cvoro A; Ayers SD; Webb P; Reinach PS; Skaf MS; Polikarpov I
Mol Pharmacol; 2012 Jun; 81(6):788-99. PubMed ID: 22391103
[TBL] [Abstract][Full Text] [Related]
37. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D
Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873
[TBL] [Abstract][Full Text] [Related]
38. Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy.
Hung YW; Hung SW; Wu YC; Wong LK; Lai MT; Shih YH; Lee TS; Lin YY
Brain Behav Immun; 2015 Jan; 43():118-29. PubMed ID: 25135858
[TBL] [Abstract][Full Text] [Related]
39. [The effects of soluble epoxide hydrolase inhibitors on cholesterol efflux in adipocytes].
Jiang Y; Xu DY; Zhao SP; Liu YW; Zhao TT; DU JQ
Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):235-9. PubMed ID: 21600089
[TBL] [Abstract][Full Text] [Related]
40. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]